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Tie1 is a mechanistically poorly characterized
endothelial cell (EC)-specific orphan receptor. Yet,
Tie1 deletion is embryonic lethal and Tie1 has been
implicated in critical vascular pathologies, including
atherosclerosis and tumor angiogenesis. Here, we
show that Tie1 does not function independently but
exerts context-dependent effects on the related re-
ceptor Tie2. Tie1 was identified as an EC activation
marker that is expressed during angiogenesis by a
subset of angiogenic tip and remodeling stalk cells
and downregulated in the adult quiescent vascu-
lature. Functionally, Tie1 expression by angiogenic
EC contributes to shaping the tip cell phenotype by
negatively regulating Tie2 surface presentation. In
contrast, Tie1 acts in remodeling stalk cells coopera-
tively to sustain Tie2 signaling. Collectively, our data
support an interactive model of Tie1 and Tie2 func-
tion, in which dynamically regulated Tie1 versus
Tie2 expression determines the net positive or nega-
tive effect of Tie1 on Tie2 signaling.
INTRODUCTION
Blood vessel formation and patterning during angiogenesis is
a multistep process that requires the precisely coordinated
engagement of different signaling pathways in endothelial cellsCell Rep(ECs) (Herbert and Stainier, 2011). The vascular endothelial
growth factor (VEGF)/VEGFR and Delta/Notch pathways act in
concert to shape the properties of ECs during sprouting angio-
genesis (Hellstro¨m et al., 2007; Phng and Gerhardt, 2009; Po-
tente et al., 2011). Sprouting tip cells, which extend filopodia
andmigrate toward angiogenic stimuli, are followed by so-called
stalk cells that proliferate to extend the sprout (Gerhardt and Bet-
sholtz, 2005; Gerhardt et al., 2003). ECs of newly formed sprouts
recruit pericytes, which leads to vessel maturation with ECs
acquiring the so-called quiescent phalanx phenotype of resting
blood vessels (Gerald et al., 2013; Mazzone et al., 2009).
Although ECs acquire specific phenotypes during the individual
steps of the angiogenic cascade, several studies have demon-
strated dynamic rearrangements and plasticity of the tip, stalk,
and phalanx cell phenotypes (Arima et al., 2011; Bentley et al.,
2014).
The angiopoietin (Ang)/Tie-signaling pathway is essential for
vessel remodeling and maturation (Augustin et al., 2009). Tie2
serves as the primary receptor of the Ang/Tie axis, transducing
Ang1-mediated EC survival and maturation signals. In turn,
Ang2 serves as context-dependent partial Tie2 agonist destabi-
lizing ECs in the presence of Ang1 and activating Tie2 in the
absence of the primary agonistic ligand Ang1 (Daly et al., 2013;
Yuan et al., 2009). In contrast to the increasingly well understood
Ang1/Ang2/Tie2 axis, the signaling mechanisms of the second
Tie receptor, Tie1, remain largely unknown (Fukuhara et al.,
2008; Saharinen et al., 2005, 2008; Seegar et al., 2010; Yuan
et al., 2007). Despite extensive research, Tie1 continues to
be an orphan receptor that does not serve as high-affinity
angiopoietin receptor. Nevertheless, the late embryonic lethalorts 12, 1761–1773, September 22, 2015 ª2015 The Authors 1761
phenotype of Tie1-deficient mice is an unambiguous demonstra-
tion of the essential requirement of Tie1 for normal vascular
development and function (Puri et al., 1995; Sato et al., 1995).
Mice lacking Tie1 die between embryonic day (E) 13.5 and birth
from widespread edema due to perturbed microvessel integrity
and lymphatic defects (D’Amico et al., 2010; Qu et al., 2010).
Moreover, recent work has established that Tie1 is not just
involved in embryonic vascular remodeling but also exerts crit-
ical functions in pathological adult vasculature, regulating tumor
angiogenesis and atherosclerotic progression (D’Amico et al.,
2014; Woo et al., 2011). Tie1 has even been proposed to be
involved in the pathogenesis of Ebola virus infection (Rasmussen
et al., 2014). Correspondingly, Tie1 expression is induced upon
endothelial activation by hypoxia and VEGF as well as by
disturbed blood flow at vessel bifurcations (McCarthy et al.,
1998; Porat et al., 2004). This is in intriguing contrast to Tie2,
which is transcriptionally downregulated upon EC activation
notably in the angiogenic tip cells but is uniformly expressed in
stalk and phalanx cells (del Toro et al., 2010; Felcht et al., 2012).
Tie1 has been proposed to serve as an endothelial mechano-
sensor because its expression is regulated by hemodynamic
shear stress (Chen-Konak et al., 2003; Porat et al., 2004; Woo
et al., 2011). This could suggest a potential role of Tie1 in
blood-flow-regulated vascular pruning as it occurs during late
angiogenic vascular remodeling (Potente et al., 2011). Moreover,
Tie1-Tie2 interactions have been implicated in the regulation of
Ang1-induced Tie2 signal transduction (Saharinen et al., 2005;
Seegar et al., 2010), indicating ligand-independent functions of
Tie1. Taking into consideration (1) the essential role of Tie1 dur-
ing embryonic development, (2) the apparent differential expres-
sion of Tie1 and Tie2, (3) the demonstrated interaction of Tie1
and Tie2, and (4) the absence of a cognate Tie1 ligand, we hy-
pothesized that Tie1 may exert its vascular-specific functions
by acting as a dynamically regulated co-receptor of Tie2. To
address this hypothesis, we studied Tie1 expression, signaling,
and function in relation to Tie2 in cellular loss-of-function and
gain-of-function experiments as well as in genetic in vivo
models. The experiments identified Tie1 as a context-dependent
modulator of Tie2 exerting negative effects on Tie2 in sprouting
tip cells and positive effects on Tie2 in remodeling stalk cells.
Quiescent phalanx cells were identified as Tie1-low, being
mainly under the control of Tie2.
RESULTS
Tie1 Is Expressed by a Subset of Angiogenic and
Remodeling ECs in the Postnatal Mouse Retinal
Vasculature
Previous studies have demonstrated the ubiquitous pan-endo-
thelial expression of Tie1 during mouse embryonic development
using transgenic mice expressing either Cre recombinase or re-
porters such as GFP and LacZ under the control of a minimal
Tie1 promoter region (Gustafsson et al., 2001; Iljin et al., 2002;
Korhonen et al., 1995). In adult mice, however, contradictory
data for Tie1 expression have been reported using different
reporter systems (Gustafsson et al., 2001; Iljin et al., 2002). To
unambiguously clarify Tie1 expression in developing and quies-
cent vasculature, we isolated ECs from the lungs of postnatal1762 Cell Reports 12, 1761–1773, September 22, 2015 ª2015 The Aday (P) 6 mice as well as adult mice by fluorescence-activated
cell sorting (FACS) (Korn et al., 2014) and assessed Tie1 expres-
sion by qRT-PCR. Whereas EC from P6 mice prominently
expressed Tie1, Tie1 expression in adult ECs was strongly
downregulated (Figure 1A). Next, we analyzed Tie1 mRNA
expression by in situ hybridization (ISH) of P6 whole-mounted
retinas. Staining for the anti-sense probe revealed Tie1 expres-
sion in a subset of tip cells (Figure 1B) and a subset of stalk cells
in the plexus region (Figures 1C and 1D). Hybridization with a
sense probe confirmed the specificity of anti-sense ISH stainings
(Figure S1A).
In order to confirm the Tie1 ISH data on the protein level, we
generated a novel monoclonal antibody (mAb) that specifically
recognized the intracellular domain of murine Tie1 (designated
5F5). The specificity of mAb 5F5 immunostaining for Tie1 was
validated on retinal tissue of mice with conditional EC-specific
deletion of Tie1, ruling out any cross-reactivity with other
molecules including Tie2 (Figure S1B). In P6 wild-type mice,
mAb 5F5 detected a subset of tip cells in the angiogenic front
(Figure 1E). Likewise, in the remodeling plexus region, 5F5
detected only a subset of ECs (Figure 1F). An overview of the
arterial branch demonstrated themosaic pattern of 5F5 immuno-
reactivity in the developing vasculature (Figure 1G). Conversely,
we confirmed that Tie2 is downregulated in tip cells and homo-
genously expressed in stalk cells (Figure 1H) (del Toro et al.,
2010; Felcht et al., 2012).
Because both ISH and immunostaining revealed a rather un-
usual mosaic pattern of Tie1 expression in tip and stalk cells,
we performed genetic reporter staining as a third approach to
stain for Tie1 expression. We generated toward this end Tie1-
MeriCreMer (Tie1MiCreM/+) knockin mice, in which a tamoxifen-
inducible form of Cre recombinase was expressed under the
control of the endogenous Tie1 promoter (Figures S1C–S1F).
To detect Cre activity, Tie1MiCreM/+ mice were bred to Rosa26
yellow fluorescent protein (YFP) reporter mice (Srinivas et al.,
2001). Upon single-dose tamoxifen treatment (P3 or P5), Tie1
promoter-driven YFP expression allowed the detection of Tie1-
expressing cells (Figure S2A). Analysis of P6 retinas identified
YFP+ cells, reflecting Tie1 promoter activity, in a subset of angio-
genic tip cells (Figure 1I) as well as in a subset of ECs in the
plexus region (Figures 1J and 1K). Thus, YFP+ EC showed a
mosaic Tie1 expression pattern compatible with the Tie1 ISH
and immunostaining data. Moreover, flow cytometric analyses
revealed that YFP+ EC comprised around 2% of the total ECs
in the lungs of P6 mice (Figure S2B). We subsequently isolated
the YFP+EC and YFPEC populations using FACS and analyzed
gene expression. No significant difference in PECAM1 expres-
sion, a pan-EC marker, was observed in the two EC populations
(Figure S2C). Yet, TIE1 expression wasmore than 2-fold upregu-
lated in YFP+EC compared to YFPEC (Figure 1L), suggesting a
correlation between Tie1 promoter activity and Tie1 transcript
levels in this subset of ECs.
Tie1 Counter-Regulates Tie2 Cell Surface Presentation
in Tip Cells but Does Not Signal Independently of Tie2
To determine the role of Tie1 in tip cells, we recapitulated tip
cell-like conditions in vitro by depleting Tie2 in sub-confluent
HUVEC. qRT-PCR analysis validated a significant decrease inuthors
Figure 1. Tie1 Is Expressed by a Subset of Tip and Stalk Cells
(A) TIE1 expression analyses of FACS-sorted lung ECs showing significant downregulation in adult mice compared to 6-day-old (P6) pups (n = 4 mice/group).
(B–D) Representative images showing ISH against Tie1 mRNA and blood vessels stained with isolectinB-4 (IB-4) at the sprouting front (B; arrows indicate stained
tip cells, whereas arrowheads indicate unstained tip cells) and in the central plexus region (C and D) of whole-mounted P6 retina.
(E–G) Representative images of Tie1 immunostaining and blood vessels stained with IB-4 in the sprouting front region (E; arrows indicate Tie1-stained tip cells;
arrowheads indicate unstained tip cells) and in the central plexus region (F) of whole-mounted P6 retina. (G) Overview image of the retinal vasculature showing
mosaic pattern of Tie1 immunostaining is shown.
(H) Representative image of Tie2 immunostaining and blood vessels (CD31) showing Tie2-negative tip cells (arrowheads) and homogenous Tie2 staining in the
plexus in P6 retina.
(I–K) Representative images of Tie1MiCreM/+ knockin-Rosa26YFP reporter mouse retina after tamoxifen treatment showing YFP expression (arrows) in a subset of
tip cells (I; arrowheads indicate YFP-negative tip cells) and in a subset of stalk cells in the plexus region (J). (K) Overview of the retinal vasculature of reporter mice
illustrating mosaic YFP expression pattern is shown.
(L) Relative TIE1 expression in YFP+ EC compared to YFP EC of P6 reporter mice post-tamoxifen (EC from five to seven littermates pooled; n = 4 independent
experiments).
*p < 0.05; **p < 0.01. The scale bar represents 50 mm. See also Figures S1 and S2.TIE2 expression by two independent siRNAs (siTie2a and si-
Tie2b) compared to non-silenced (NS) control siRNA (Figure 2A).
Tie2 silencing resulted in the transcriptional upregulation of TIE1
as well as the expression of known tip cell-enriched genes such
as DLL4, VEGFR2, and ANGPT2 (Figures 2A and 2B), demon-
strating that the forced downregulation of Tie2 was sufficient to
drive the tip cell program. Conversely, we also studied the effect
of siRNA-mediated Tie1 silencing (siTie1a and siTie1b) on Tie2
and vice versa in sub-confluent HUVEC. Tie1 silencing did notCell Repsignificantly alter TIE2 transcript levels in sub-confluent cells
(Figure 2C), but Tie2 protein was increased (Figures 2D and
2E). Tie2 depletion in turn resulted in a modest increase in Tie1
protein (Figures 2D and 2E). Flow cytometric analysis of non-per-
meabilized HUVEC showed that the surface pool of Tie2 recep-
tor was increased upon loss of Tie1 (Figure 2F). Tie2 knockdown,
however, weakly affected the surface pool of Tie1 (Figure 2G).
Taken together, the experiments revealed that Tie1 counter-
balanced Tie2 cell surface presentation in tip-like ECs.orts 12, 1761–1773, September 22, 2015 ª2015 The Authors 1763
Figure 2. Tie1 Counter-Balances Tie2 Expression in Tip Cells
(A and B) Mimicking tip cell conditions in vitro by siRNA-mediated knockdown of Tie2 in sub-confluent HUVEC caused significant upregulation (A) of TIE1 and (B)
of known tip cell-enriched genes like DLL4, VEGFR2, and ANGPT2 (NS, non-silenced control; siTie2a and siTie2b, two independent Tie2 siRNAs; n = 3).
(C) Tie1 silencing under similar conditions did not alter TIE2 expression (siTie1a and siTie1b, two independent Tie1 siRNAs; n = 3; n.s., not significant).
(D and E) Western blot analyses and densitometric quantification demonstrating an increase in Tie2 protein upon Tie1 silencing and vice versa (n = 3).
(F and G) Flow cytometric analyses of siTie1 compared to control, non-permeabilized HUVEC showing a significant increase in surface presented pool of Tie2
upon Tie1 depletion. Tie2 silencing did not affect Tie1 surface presentation compared to control. Insets show isotype controls, and numbers indicate geometric
mean fluorescence intensity.
(H and I) Mosaic spheroid competition sprouting assay with 1:1 mixture of wild-type (WT), and Tie1-overexpressing (Tie1-GFP, green) HUVEC showing reduced
contribution of Tie1-GFP cells in sprouts and tips compared to WT cells. Arrows indicate WT tips, whereas arrowheads show Tie1-GFP-positive tips.
(legend continued on next page)
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Because only a subset of tip cells expressed Tie1, we as-
sessed the potential of Tie1-overexpressing HUVEC (Tie1-
GFP) in competition with wild-type (WT) HUVEC to acquire the
tip cell position by performing mosaic spheroid sprouting
assays. Toward this end, a 1:1 mixture of WT and Tie1-GFP ex-
pressing HUVEC was subjected to VEGF-induced sprouting in a
3D collagen matrix (Figure 2H). Tie1-GFP cells were under-rep-
resented both in the sprouts (35%) and even more so in the tip
cell position (21%) compared to WT cells (Figure 2I). Similarly,
when 1:1 mixtures of monolayer-cultured WT:Tie1-GFP cells
were allowed to migrate in a scratch wound assay, Tie1-GFP-
expressing ECs comprised only 19% of the total ECs at the
migrating front (Figures 2J and 2K). Thus, these mosaic compe-
tition experiments imply that Tie1 expression did not functionally
favor the tip cell position, even though a subset of tip cells upre-
gulated Tie1.
Next, we askedwhether Tie1 exerted functions in Tie2-low EC.
In cultured EC, recombinant Ang1, but not Ang2, induced Tie2
phosphorylation as well as Akt and Erk activation (Figure S3A).
Tie1 was weakly phosphorylated upon Ang1 stimulation (Fig-
ure 2L), confirming previously reported findings (Saharinen
et al., 2005). Yet, Ang1 did not phosphorylate Tie1 in the absence
of Tie2 (Figure 2L), suggesting that Tie1 phosphorylation was
Tie2-dependent. It has previously been shown that Tie1 acti-
vates phosphoinositide 3-kinase (PI3K)-mediated Akt survival
signaling (Kontos et al., 2002). Accordingly, Tie1 knockdown
increased EC apoptosis in response to serum-deprivation stress
(Figure 2M) but did not affect EC proliferation (Figure S3B). Taken
together, EC activation upregulated Tie1 expression, which
countered Tie2 cell surface presentation to possibly suppress
Tie2 in tip cells. However, the Tie1 expression in tip cells could
be transient as Tie1 cannot function independently of Tie2, and
therefore, a mosaic tip cell expression pattern was observed.
Endothelial Tie1 Deletion Impairs Stalk Cell Function
and Augments Vessel Regression
Given the mosaic expression of Tie1 in the postnatal retina,
we asked whether Tie1 was required for retinal angiogenesis.
Tie1flox/flox mice (Qu et al., 2010) were crossed with endothe-
lial-specific Cdh5CreERT2 driver mice (Wang et al., 2010) to
delete Tie1 in a temporally defined manner in EC (hereafter
Tie1-ECKO). TIE1 expression was reduced by 85% in P6
Tie1-ECKO mice compared to Tie1flox/flox littermates (hereafter
Tie1-WT; Figure S4G). Confirming and extending previously
published data (D’Amico et al., 2014), whole-mount analyses
of isolectinB-4 (IB-4)-stained P6 retinal vasculature revealed an
impaired retinal vascularization in Tie1-ECKO mice, causing a
significant decrease in the radial vessel outgrowth and vascular
density compared to Tie1-WT (Figures S4A–S4C). The number of
tip cells was reduced (Figures S4D and S4E), as was the number
of branches (Figure S4F).(J) Phalloidin staining (red) of WT, Tie1-GFP (green), and 1:1 mixture of WT:Tie1-
(K) Quantification of migrated cells in the wound area showing decreased migrat
(L) Control and siTie2 HUVEC were stimulated with Ang1 or Ang2 (400 ng/ml)
immunoblotted sequentially with a pan-phosphotyrosine antibody (pTie1) and Ti
(M) Apoptosis assay after overnight serum deprivation showing increased caspa
*p < 0.05; **p < 0.01; ***p < 0.001. The scale bars represent 50 mm (H) and 100 m
Cell RepBecause loss of Tie1 during embryonic development perturbs
vascular remodeling and integrity (Dumont et al., 1994; Sato
et al., 1995), we next assessed whether the reduced vascular-
ization in Tie1-ECKO retinas was due to altered stalk cell re-
modeling. Postnatal EC deletion of Tie1 resulted in excessive
regression of vessels in the plexus region as evidenced by
increased numbers of collagen IV (ColIV)-positive and IB-
4-negative (ColIV+IB-4) empty sleeves (Figures 3A and 3B).
Enhanced vessel regression in Tie1-ECKO mice was accompa-
nied by increased EC apoptosis marked by an elevated number
of cleaved caspase3+ EC in the retina (Figures 3C and 3D). More-
over, CD31 co-staining of retinal vessels with the EC-specific
transcription factor, ERG1 (Ets-related gene1) (Korn et al.,
2014), identified a significant reduction of total number of ECs
per retina area in Tie1-ECKO mice (Figures 3E and 3F).
To further analyze EC autonomous effects of Tie1 deletion,
pulmonary EC from Tie1flox/flox-Cdh5CreERT2 mice were isolated
and treated in culture with 4-hydroxytamoxifen (OHT), the active
metabolite of tamoxifen, to induce Cre activity and, hence, Tie1
deletion (Figures 3G and 3H). Corresponding to the apoptosis
phenotype observed in Tie1-ECKO retinas, Tie1 deletion in
cultured ECs led to significant upregulation of apoptosis-related
genes such asBAX andSTAT2 (Figure 3I). Interestingly,ANGPT2
expression was also upregulated upon Tie1 deletion (Figure 3J),
reflecting EC destabilization as it, for example, occurs during
physiological vascular regression in the cyclic ovary (Goede
et al., 1998).
Tie1 Expression under Low Shear Stress Regulates EC
Survival
Tie1 is upregulated in vascular regions exposed to disturbed flow
acting as a mechanosensor transducing changes in shear forces
(Porat et al., 2004; Woo et al., 2011). Based on the increased
vessel regression observed in Tie1-ECKO mice, we compara-
tively analyzed gene expression in Tie1-silenced (siTie1) and
non-silenced ECs (NS) cultured under static conditions or at 10
dynes/cm2 laminar flow. ECs exposed to laminar flow aligned
in the direction of flow within 48 hr (Figures 4A and 4B). Laminar
shear stress led to the induction of the established shear-
stress-regulated transcription factor KLF2 (Parmar et al., 2006)
and the KLF2-regulated genes TIE2 and NOS3 as well as
reduced ANGPT2 in control cells (Figure 4C). Laminar flow also
led to downregulation of TIE1 expression, confirming previous
findings of the negative regulation of Tie1 by laminar flow
(Chen-Konak et al., 2003; Woo et al., 2011). Accordingly, forced
silencing of Tie1 did not affect TIE2, KLF2, NOS3, and ANGPT2
expression under flow conditions compared to control cells. In
turn, Tie1 deletion under static conditions caused a significant
decrease in KLF2 and TIE2 expression, whereas upregulating
ANGPT2 (Figure 4C). Additionally, KLF2 was significantly down-
regulated upon Tie1 deletion in pulmonary ECs isolated fromGFP HUVEC subjected to scratch wound assay (dotted lines).
ion of Tie1-GFP cells in competition with WT EC.
for 20 min. Cell lysates were either immunoprecipitated with anti-Tie1 and
e1 or probed with antibodies against Tie2, pAkt, total Akt, and actin.
se activity in Tie1-silenced HUVEC compared to control (n = 3).
m (J). See also Figure S3.
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Figure 3. Tie1 Deletion Increases Vessel
Regression and EC Apoptosis in the Retinal
Vasculature
(A and B) Representative images of Tie1-WT and
Tie1-ECKO retina from P6 mice post-tamoxifen
treatment co-stained with (A) IB-4 and collagen IV
(ColIV). Arrowheads indicate IB-4ColIV+ empty
sleeves quantified in (B) (n = 7–11 mice/group).
(C and D) IB-4 and cleaved caspase3 (C). Arrow-
heads indicate cleaved caspase3+; IB-4+ EC
quantified in (D) (n = 8–10 mice/group).
(E and F) Quantitation of CD31 and ERG1 to count
the total number of EC in the retinal vasculature (E);
ERG1+ nuclei quantified in (F) (n = 7 mice/group).
(G–J) Murine lung ECs isolated from Tie1flox/flox-
Cdh5CreERT2 P6 mice and cultured without treat-
ment (OHT) or with active tamoxifen metabolite
(+OHT) to induce Tie1 deletion in vitro. (G) qRT-
PCR and (H) western blot analyses showing
significant downregulation of Tie1 upon treatment
are shown. (I) Gene expression analyses demon-
strating an increase in apoptosis-related genes
(BAX and STAT2) and (J) ANGPT2 expression after
OHT treatment (n = 3) are shown.
*p < 0.05; ***p < 0.001. The scale bar represents
100 mm. Images (A), (C), and (E) are composite of
tiled and automatically stitched images. See also
Figure S4.Tie1flox/flox-Cdh5CreERT2 mice and treated in culture with 4-OHT
compared to untreated cells (Figure 4D). Thus, induction of TIE1
expression under conditions of low shear stress or no blood flow
such as in the regressing endothelium regulates KLF2 and TIE2
expression, thereby maintaining EC survival during the process
of vessel remodeling (Figure 4E). In contrast, absence of Tie1
in remodeling EC exposed to no blood flow conditions reduced
the expression of pro-survival factors such as KLF2 and TIE2,
resulting in EC apoptosis (Figure 4F).
Tie1 Sustains Ang1-Tie2 Signaling
Pronounced vessel regression of stalk cells in Tie1-ECKO mice
and the mechanosensory role of Tie1 in the remodeling vascu-
lature pointed toward potential signaling roles of Tie1 during
vessel remodeling. To assess the contribution of Tie1 to Ang1-
Tie2 signaling during remodeling and maturation, we performed
Ang1 stimulation experiments in confluent Tie1-silenced ECs.
Prolonged Ang1 stimulation of Tie1-silenced confluent ECs led1766 Cell Reports 12, 1761–1773, September 22, 2015 ª2015 The Authorsto reduced total Tie2 protein and Tie2
phosphorylation (pTie2) (Figure 5A).
Plotting pTie2 signal intensity over time
of Ang1 stimulation demonstrated sus-
tained Ang1-induced pTie2 levels in
control cells (Figure 5B). Although loss
of Tie1 induced phosphorylation similarly
in both cell populations, pTie2 levels
declined significantly faster in Tie1-
silenced cells compared to control cells
(Figure 5B). Correspondingly, Ang1-
mediated Akt activation downstream of
pTie2 was downregulated in the absenceof Tie1 (Figures 5C and 5D). Tie1 loss did not, however, alter Erk
activation (Figure 5C). Furthermore, as total Tie2 protein was
affected upon Tie1 silencing, we studied Tie2 protein turnover
by inducing Ang1-mediated Tie2 internalization in Tie1-silenced
cells compared to control cells. Accelerated loss of total Tie2
was observed in siTie1 cells compared to NS, indicating that
Tie1 deletion accelerated Tie2 degradation (Figure S5).
To investigate how Tie1 sustained Ang1-Tie2 signaling in
confluent ECs, we analyzed Tie1 localization in relation to Tie2
in Ang1-stimulated EC monolayers. Confirming previous reports
(Saharinen et al., 2005), there was increased co-localization of
Tie1 and Tie2 especially at cell-cell contacts upon Ang1 stimu-
lation compared to unstimulated ECs (Figure 5E), suggesting
that Tie1-Tie2 heterodimers served as a signaling-incompetent
(Hansen et al., 2010) reservoir for sustained Tie2 signaling.
Because loss of Tie1 affected Tie2 protein turnover in the
presence of Ang1, we traced the fate of internalized Tie2 in Tie1-
silenced and control ECs using an antibody uptake assay. In this
Figure 4. Low-Shear-Stress-Induced Tie1 Expression Regulates KLF2 and TIE2 Expression
(A and B) Representative images showing HUVEC alignment upon shear stress after 48 hr of laminar flow at 10 dynes/cm2 compared to cells cultured under static
flow conditions without shear stress.
(C) Gene expression analyses of Tie1-silenced (siTie1) and control (NS) HUVECwith no flow compared to siTie1 and control cells exposed to laminar flow. Relative
TIE1, TIE2, KLF2, NOS3, and ANGPT2 expression normalized to respective gene expression in control, no flow condition is shown (n = 4).
(D) qRT-PCR analysis showing downregulation of KLF2 expression in murine lung ECs upon Tie1 deletion in vitro by treatment with active tamoxifen metabolite
(+OHT) compared to untreated cells (OHT; n = 3).
(E) Tie1 expression under no flow conditions regulates KLF2-mediated EC survival by regulating Tie2 and repressing Ang2.
(F) Loss of endothelial Tie1 under no flow conditions causes downregulation of KLF2 and Tie2 survival genes and increase in Ang2 expression causing EC
apoptosis.
*p < 0.05; ***p < 0.001.assay, the surface-presentedpool of Tie2was labeledwith a Tie2-
specific antibody binding to its extracellular domain followed by
Ang1 stimulation, causing internalization of labeled receptors.
The internalized fraction of Tie2 co-localized at similar abun-
dance with LAMP1, a marker of the lysosomal compartment,
within 15 min of Ang1 stimulation in both cell populations. How-
ever, a significant increase in co-localization was observed in
Tie1-silenced cells after 60 min of Ang1 stimulation compared to
control, suggesting increased trafficking over time of Tie2 to the
lysosomal pathway in the absence of Tie1 (Figures 5F and 5G).
Double Deficiency of Tie1 and Tie2 Suppresses Tip Cell
Sprouting and Impairs Stalk Cell Remodeling
To examine the role of Tie1-Tie2 interaction during angiogenesis
in vivo, we generated a conditional knockout mouse model tar-Cell Repgeting both Tie1 (Tie1flox/flox) and Tie2 (Tie2flox/flox) and bred these
mice to endothelial-specific Cdh5CreERT2 driver mice (Tie1Tie2-
ECKO). Postnatal tamoxifen induction resulted in 80% down-
regulation of TIE1 expression and 55% reduction of TIE2 expres-
sion in these triple-transgenic pups (Figure S6). Analysis of the
P6 whole-mount retinal vasculature labeled with IB-4 demon-
strated a significant reduction in radial vessel outgrowth and
vascularized area in the Tie1Tie2-ECKO retinal vasculature
compared to Tie1flox/flox/Tie2flox/flox (hereafter Tie1Tie2-WT) litter-
mate control mice (Figures 6A–6C). The number of tips and
branches was also reduced in double-deficient retinas (Figures
6D–6F). Abnormal clustering of ECs at the sprouting front was
observed in Tie1Tie2-ECKO retina (Figure 6D, arrows), which
was not observed in Tie1-ECKO (Figure S4) or in Tie2-ECKO
(Figure S7) mice.orts 12, 1761–1773, September 22, 2015 ª2015 The Authors 1767
Figure 5. Tie1 Sustains Ang1-Tie2 Signaling in Stalk Cells
(A) Effect of Tie1 knockdown in confluent HUVEC on Ang1-induced Tie2 phosphorylation at different time points of Ang1 stimulation (15, 30, and 60 min). Cell
lysates were either immunoprecipitated with anti-Tie2 and immunoblotted sequentially with pan-phosphotyrosine (pTie2) and Tie2 antibodies or probed with
antibodies against Tie1 and actin loading control.
(B) Densitometric analysis of pTie2 showing declining pTie2 levels in siTie1 cells compared to sustained pTie2 levels in control cells (n = 3).
(C) Immunoblots showing the effect of Tie1 silencing on Ang1-mediated activation of Akt and Erk survival pathways.
(D) Densitometric quantification of pAkt to Akt ratio demonstrating a significant decrease in pAkt upon siTie1 compared to corresponding controls (n = 3).
(E) Immunofluorescence staining of Tie1 and Tie2 in HUVEC monolayers showing increased co-localization of Tie1 and Tie2 upon Ang1 stimulation compared to
unstimulated control.
(F) Tie1-silenced and control ECs were incubated with an anti-Tie2 antibody to label the surface-presented Tie2 and stimulated with 400 ng/ml Ang1 for ligand-
induced Tie2 internalization. Immunofluorescence staining of internalized Tie2 and lysosomal marker, LAMP1, showing Tie2 localization in the lysosomal
compartment (arrows in higher magnification of boxed areas) is shown.
(G) Tie2-LAMP1 co-localization analyses showing significant increase of Tie2 in the lysosomes upon Tie1 silencing compared to control at the 60 min time point
(n = 7 or 8 microscopic fields/condition).
*p < 0.05; **p < 0.01. The scale bars represent 10 mm (E) and 20 mm (F). See also Figure S5.
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Figure 6. Suppressed Angiogenesis in Tie1
and Tie2 Double-Deficient Mice
(A) Representative images of IB-4-labeled P6
retinal vasculature of Tie1Tie2-WT and Tie1Tie2-
ECKO mice post-tamoxifen treatment.
(B and C) Vascular analyses showing significant
decrease in (B) vascular outgrowth and (C) relative
vessel area in Tie1Tie2-ECKO mice compared to
WT littermates (n = 10 or 11 mice/group).
(D) Vascular front of Tie1Tie2-ECKOmice showing
unusual clustering of ECs (arrows).
(E and F) Number of tips/mm vascular front (E) and
number of branches (F) were also reduced in
Tie1Tie2-ECKO mice (n = 10 or 11 mice/group).
***p < 0.001. The scale bars represent 1 mm (A)
and 100 mm (D). Images (A) and (D) are composite
of tiled and automatically stitched images. See
also Figures S6 and S7.To determine whether Tie1 and Tie2 together play a role in the
remodeling stalk cell vasculature, we analyzed ColIV+IB-4
empty basement sleeves in Tie1Tie2-WT and Tie1Tie2-ECKO
mice. Genetic deletion of both receptors resulted in a significant
increase in vessel regression in the proximal remodeling plexus
region of P6 retina (Figures 7A and 7B). This increase was
accompanied by enhanced EC apoptosis, which was assessed
by cleaved caspase3+ EC staining (Figures 7C and 7D). The
remodeling defects observed in Tie1Tie2-ECKO mice were
more pronounced compared to Tie1-ECKO (Figure 3) mice, indi-
cating cooperative functions of Tie1 and Tie2, particularly during
vascular remodeling. Interestingly, the pericyte coverage of
retinal vasculature analyzed by desmin staining was increased
in Tie1Tie2-ECKO mice compared to Tie1Tie2-WT (Figures 7E
and 7F), reflecting the preferential regression of immature,
non-pericyte-covered microvessels in Tie1Tie2-ECKO mice.
DISCUSSION
The molecules and mechanisms controlling sprouting angio-
genesis have been unraveled in substantial molecular detail. In
contrast, the mechanisms of vessel remodeling and maturation
are much-less well understood. The Ang/Tie system is a pro-
totypic regulator of vessel maturation and remodeling. The
agonistic ligand Ang1 activates Tie2-transducing survival and
quiescence signals including the PI3K/Akt pathway. The partial
agonist Ang2 acts as a context-dependent weak stimulator or
inhibitor of Tie2. Tie1, on the other hand, may be phosphorylated
upon Ang1 or Ang4 stimulation (Saharinen et al., 2005). Likewise,
phosphorylation of a chimeric form of Tie1 has been shown
to activate the PI3K/Akt pathway (Kontos et al., 2002). Yet, it
has not been established whether this may occur as a direct
consequence of Tie1 phosphorylation or as a result of a crosstalk
with Tie2.
This study was aimed at systematically studying Tie1 expres-
sion and function during angiogenesis and vascular remodeling.
Employing novel Tie1-specific tools (mAb 5F5, Tie1MiCreM/+
knockin-driven reporter mice, and Tie1Tie2 double-ECKO
mice) and performing functional assays in vitro and in vivo, weCell Repshow that (1) TIE1 expression is upregulated in a subset of angio-
genic and remodeling ECs but downregulated in the quiescent
vasculature in the adult; (2) Tie1 counter-regulates Tie2 cell sur-
face presentation in tip cells; (3) low shear stress-dependent
TIE1 expression regulates TIE2 and KLF2, enabling efficient
vascular remodeling; (4) Tie1 sustains Ang1-Tie2 signaling in
remodeling stalk cells, promoting EC survival; and (5) the func-
tional synergism of Tie1 and Tie2 is essential for efficient angio-
genesis and remodeling. Collectively, the data establish that Tie1
functions by negatively and positively affecting Tie2 expression
and function in a context-dependent manner to fine-tune Tie2
during sprouting angiogenesis (negative regulation of Tie2 sur-
face presentation) and vascular remodeling (sustaining Tie2
signaling; Figure 7G).
Tie1 has previously been shown to be dynamically expressed
upon exogenous activation. Induction by VEGF, turbulent shear
stress, and hypoxia all hinted at a positive role of Tie1 during
sprouting angiogenesis (Chen-Konak et al., 2003; Porat et al.,
2004). Conversely, the negative transcriptional regulation of
Tie1 under conditions of laminar flow suggested reduced Tie1
expression in quiescent ECs (Woo et al., 2011). Indeed, employ-
ing quantitative FACS, we observed the strong downregulation
of endothelial Tie1 expression in adult mice compared to P6
mice, suggesting a possible role of Tie1 during active angiogen-
esis. To further dissect Tie1 function during postnatal angiogen-
esis, we studied its positional expression in the tip and stalk cell
context. Employing three independent approaches including
ISH, immunostaining, and an inducible reporter mouse, we iden-
tified a mosaic expression pattern of Tie1 in the angiogenic and
remodeling postnatal retinal vasculature. Using b-gal staining in
Tie1+/lacZ mice, a recent study has suggested homogenous Tie1
expression in the postnatal retina (D’Amico et al., 2014). Yet, our
study revealed a more-complex pattern of Tie1 expression in the
retina vasculature. The observed mosaic pattern clearly demon-
strated the transient and dynamic nature of Tie1 expression in
the retinal vasculature. Moreover, the downregulation of Tie1 in
the adult vasculature validated Tie1 as an EC activation marker
and suggested that Tie1 may therapeutically be an attractive
target molecule.orts 12, 1761–1773, September 22, 2015 ª2015 The Authors 1769
(legend on next page)
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Tie1 expression in a subset of tip cells supports a role of Tie1
during sprouting angiogenesis. Indeed, postnatal deletion of
Tie1 in ECs led to reduced tip cells and defective stalk cell re-
modeling. However, cellular competition experiments revealed
no preference of Tie1-overexpressing cells for acquiring the tip
cell position. Subsequent experiments showed that upregulation
of Tie1 in tip-like cells served to negatively regulate Tie2 surface
presentation, which was strongly downregulated during sprout-
ing angiogenesis. In fact, we observed that the forced down-
regulation of Tie2 was sufficient to trigger the tip cell phenotype,
suggesting that downregulated Tie2 is indeed an important
determinant of tip cell function. To relate mosaic tip cell Tie1
expression to its function, time-lapse imaging studies of the
sprouting endothelium are required. Such studies have previ-
ously identified the dynamic positional shuffling of tip and stalk
cells, depending on constant re-evaluation of VEGF/VEGFR
and Delta/Notch pathways (Jakobsson et al., 2010). Along these
lines, a potential crosstalk between Tie1 andDelta/Notch system
has been implicated because the anti-angiogenic effects of
Tie1 deletion correlate with upregulation of the Notch pathway
(D’Amico et al., 2014). Thus, our findings may guide future
studies focusing on dynamic cell rearrangements of Tie1-ex-
pressing ECs and crosstalk between the Ang/Tie and Delta/
Notch pathways. Interestingly, factors like VEGF and phorbol es-
ters that cause EC activation and upregulation of Tie1 expression
are also known to reduce the endothelial Tie1 surface pool by
inducing proteolytic shedding of its extracellular domain, arguing
for a transient role of Tie1 in tip cells (Singh et al., 2012; Tsiamis
et al., 2002; Yabkowitz et al., 1999).
Tie2 signaling serves as an important regulator of vascular
remodeling and maturation (Augustin et al., 2009). This study
revealed an essential role of Tie1 in remodeling stalk cells as a
modulator of Tie2 signaling. EC-specific deletion of Tie1 resulted
in enhanced vessel regression in the retina due to EC apoptosis-
induced pruning of the vasculature. Endothelial apoptosis and
vessel pruning are driven by low shear stress in constricted, hy-
poperfused vessels (Korn and Augustin, 2015; Potente et al.,
2011). Low shear-stress-induced Tie1 expression was associ-
ated with the expression of the shear-stress-responsive tran-
scription factor KLF2. Increased expression of KLF2 is known
to induce TIE2, whereas potently suppressing ANGPT2 to pro-
mote EC survival (Parmar et al., 2006). Tie1 loss also resulted
in transcriptional upregulation of ANGPT2 both in vitro as well
as in Tie1-ECKOmice. Ang2 overexpression promotes EC death
and vessel regression particularly in the absence of VEGF (Cao
et al., 2007; Lobov et al., 2002). As such, increased vessel
regression in Tie1-ECKO mice could be attributed to the loss
of KLF2-mediated Tie2 expression and increased Ang2, leadingFigure 7. Loss of Tie1 and Tie2 Causes Enhanced Vessel Regression i
(A–D) Representative images of Tie1Tie2-WT and Tie1Tie2-ECKO P6 retinal vas
collagen IV (ColIV); arrowheads indicate IB-4ColIV+ empty sleeves quantified i
cleaved caspase3+; IB-4+ EC quantified in (D) (n = 8 or 9 mice/group).
(E and F) Representative images showing (E) desmin-positive pericyte coverage
fication (F; n = 10 mice/group).
(G) Model demonstrating the contextual role of Tie1 counter-regulating Tie2 cell
cells by forming heterocomplexes.
*p < 0.05, ***p < 0.001. The scale bar represents 100 mm. Images (A), (C), and (E
Cell Repto EC apoptosis. Thus, the mechanosensory function of Tie1 in
the remodeling ECs at sites of low blood flow is essential for
EC survival and efficient remodeling.
During vascular maturation, the Ang1-Tie2-signaling axis is
active in remodeling stalk cells, which recruit pericytes to
achieve stability. Furthermore, activation of membrane recep-
tors by ligands enhances endocytosis, causing downregulation
of receptor abundance on the cell surface (Goh and Sorkin,
2013). We show that Tie1 sustains Ang1-Tie2 signaling poten-
tially by forming heteromeric Tie1-Tie2 complexes that prevent
Tie2 from being rapidly internalized and perpetuate Tie2
signaling. Tie1 thereby promotes the anti-apoptotic effects of
Ang1 by enhancing Akt activation and EC survival. This func-
tional cooperativity between Tie1 and Tie2 suggested by cellular
experiments could be confirmed in vivo using EC-specific dou-
ble-Tie1-Tie2 knockout mice. Postnatal vascularization was
similarly impaired in Tie1Tie2-ECKO mice as in Tie1-ECKO
mice except for the formation of vascular tufts at the sprouting
front in Tie1Tie2-ECKO mice. However, the defects in vascular
remodeling were more pronounced upon double deletion, high-
lighting the rate-limiting role of Tie1 and Tie2 interactions during
the process of vascular remodeling.
The comparison of inducible Tie1-ECKO and Tie1Tie2-ECKO
mice validated cooperative functions of Tie1 and Tie2 in a defi-
nite genetic setting. Yet, we could not readily compare these
findings to inducible Tie2-ECKO mice, because recombination
of inducible Tie2-ECKO was consistently low (30% and lower;
Figure S7), whereas it was significantly higher in Tie1Tie2-
ECKO mice. This unusual and surprising interdependence of
Tie1Tie2 genetic recombination is subject of ongoing studies.
For the purpose of the present study, the comparison of Tie1-
ECKO and Tie1Tie2-ECKO mice was useful to show that Tie1
acts to modulate Tie2 function.
In summary, this study has mechanistically unraveled the
complexity of the context-dependent modulatory role that the
orphan receptor Tie1 exerts on Tie2 signaling. Tie1 expression
by sprouting tip cells and remodeling stalk cells contextually reg-
ulates Tie2 expression, cell surface presentation, and signaling
in a ligand-independent manner. The prominent downregulation
of Tie1 in adult resting ECs and the strict activation-dependent
transcriptional upregulation make Tie1 thereby an attractive
target for therapeutic intervention aimed at interfering with the
activated EC phenotype. For example, Tie1 has recently been
proposed as a target for anti-angiogenic combination therapies
(D’Amico et al., 2014). The findings of this study may thereby
contribute to themechanism-guided development of novel com-
bination therapies with optimized balance of triggering vascular
regression and promoting vascular normalization.n the Retina
culature post-tamoxifen treatment, labeled with IB-4 and co-stained with (A)
n (B) (n = 9 or 10 mice/group) or (C) cleaved caspase3; arrowheads indicate
of blood vessels (IB-4) in Tie1Tie2-WT and Tie1Tie2-ECKO retina and quanti-
surface presentation in tip cells and sustaining Ang1-Tie2 signaling in the stalk
) are composite of tiled and automatically stitched images.
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EXPERIMENTAL PROCEDURES
Mice and Tamoxifen Injections
Generation of Mutant Tie1MiCreM/+ Mice
The cDNA of a tamoxifen-inducible codon-improved Cre recombinase (iCre)
(Shimshek et al., 2002) flanked by two mutated estrogen receptor sites
(MeriCreMer) was inserted into the first exon of the Tie1 locus in embryonic
stem cells to express the fusion protein MeriCreMer under the control of the
endogenous Tie1 promoter (Figure S1C). The knockin allele was maintained
on the C57BL/6 background. For tracing Tie1 expression, Tie1MiCreM/+ mice
were crossed to Rosa26YFP (Gt(ROSA)26Sortm1.1(EYFP)Cos) reporter mice (Srini-
vas et al., 2001) and injected with 100 mg of tamoxifen (Sigma; T5648) in 50 ml
peanut oil/5% ethanol on P3 or P5.
Tie1 and Tie2 Floxed Mice
Generation of Tie1 floxed mice has been described previously (D’Amico
et al., 2010; Qu et al., 2010), and Tie2 floxed mice were generated by the
Ingenious Targeting Laboratories (Figure S7). Tie1flox/flox and Tie2flox/flox
mice were crossed with Tg(Cdh5-cre/ERT2)1Rha (Cdh5CreERT2) mice
(Wang et al., 2010) to specifically delete endothelial Tie1 and Tie2 expres-
sion. Postnatal Cre recombination was induced by injecting 100 mg tamox-
ifen on P1–3 and P5. All animal experiments were approved by the
local regulatory committee Bezirksregierung Karlsruhe, Germany (G60/13,
G39/11, and G22/14). For further details, see the Supplemental Experi-
mental Procedures.
Additional Procedures
Please refer to the Supplemental Experimental Procedures for details on
whole-mount retina staining and image analysis, in situ hybridization, lung
EC isolation, siRNA transfection, cell culture assays, RNA isolation, qRT-
PCR, immunoprecipitation, and western blotting.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Soft-
ware) and Excel (Microsoft Office). Data are expressed as mean ± SD. Statis-
tical significance was determined by two-tailed Student’s t test. A p value of
less than 0.05 was considered statistically significant (*p < 0.05; **p < 0.01;
***p < 0.001). ‘‘n’’ represents either the number of independent experiments
or number of mice analyzed per group.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.08.024.
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